Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Hundreds of Jobs to Go as GlaxoSmithKline Shutters Manufacturing Site

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-glaxosmithkline.jpg" NAME"Hundreds of Jobs to Go at GlaxoSmithKline" ALT"Hundreds of Jobs to Go at GlaxoSmithKline"July 20, 2017By Mark Terry, BioSpace.com Breaking News StaffAs <A HREF"http://www.biospace.com... Source: BioSpace

Continue ReadingHundreds of Jobs to Go as GlaxoSmithKline Shutters Manufacturing Site

Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-sanofi.jpg" NAME"Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi" ALT"Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi"July 20, 2017By Alex Keown,…

Continue ReadingAblynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi

Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roche.jpg" NAME"Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics" ALT"Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics"July…

Continue ReadingRoche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics